Covalon Technologies Ltd. ( CVALF) - Stock Earnings
CVALF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 20, 2026, midnight | — / — | — | — / — | — |
CVALF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 359480 USD | 8.7 million USD |
| 2025Q4 | 175960 USD | 6.9 million USD |
| 2026Q1 | 1.2 million USD | 8.7 million USD |
| 2026Q3 Est. | — | — |
CVALF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2018 | — CAD | 26.7 million CAD |
| 2024 | 2.3 million USD | 31.2 million USD |
| 2025 | 2.2 million USD | 32.8 million USD |
| 2026 Est. | — | — |
CVALF
Price: $1.66
52 week price:
Dividend Yield: 6.73%
Earnings Per Share: 0.05 USD
P/E Ratio: 27.60
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 43.6 million